CDKN2A and malignant mesothelioma: Knockout mice with targeted deletion of specific Cdkn2A/Arf exons have disrupted p16Ink4a, p19Arf or both genes [1], [2], [3], [4] and develop a different spectrum of spontaneous tumors, although not malignant mesotheliomas (MMs).